May 2 |
Regeneron falls after Q1 miss; announces $3B share buybacks
|
May 2 |
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
|
May 2 |
Regeneron Earnings Miss; Biotech Giant's Stock Falls
|
May 2 |
Regeneron Pharmaceuticals misses top-line and bottom-line estimates; updates FY24 outlook
|
May 2 |
Regeneron Reports First Quarter 2024 Financial and Operating Results
|
May 1 |
Regeneron Pharmaceuticals Q1 2024 Earnings Preview
|
May 1 |
Roche’s VABYSMO has successful Q1 sales despite Regeneron and Bayer’s EYLEA HD launch
|
Apr 30 |
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
|
Apr 30 |
Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?
|
Apr 29 |
Down -8.24% in 4 Weeks, Here's Why Regeneron (REGN) Looks Ripe for a Turnaround
|